Brustein M, Kraal G, Mebius R E, Watson S R
Department of Immunology, Genentech, Inc., South San Francisco, California 94080.
J Exp Med. 1992 Nov 1;176(5):1415-9. doi: 10.1084/jem.176.5.1415.
Lymphocytes are engaged in constant trafficking from the blood into secondary lymphoid tissues, such as peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN), and Peyer's patches (PP). The initial step in this process is the binding of lymphocytes to high endothelial venules (HEV), and in the case of trafficking of cells to the PLN, it is required that they bear the L-selectin surface receptor. Using a chimeric protein, combining the extracellular domains of L-selectin with a human immunoglobulin (Ig) G1 Fc region (L-selectin-IgG), we have probed the expression of ligands for this receptor on HEV and in cell lysates. Two sulfated glycoproteins of 50 and 90 kD have been identified in lysates from PLN and MLN, but not PP. Here we show that the 50-kD molecule is secreted in organ cultures in vitro and is present in the blood of normal animals. Indeed, normal serum inhibits lymphocyte binding to HEV by approximately 50% in an in vitro assay. This inhibitory activity can be removed by passage of the serum over an L-selectin-IgG column and has a molecular mass of approximately 50 kD. We speculate on the possible reasons for secretion of a homing receptor ligand.
淋巴细胞不断地从血液进入二级淋巴组织,如外周淋巴结(PLN)、肠系膜淋巴结(MLN)和派伊尔结(PP)。这一过程的初始步骤是淋巴细胞与高内皮微静脉(HEV)结合,就细胞向PLN迁移的情况而言,要求它们带有L-选择素表面受体。利用一种嵌合蛋白,即把L-选择素的胞外结构域与人免疫球蛋白(Ig)G1 Fc区结合在一起(L-选择素-IgG),我们已经探究了该受体的配体在HEV上以及细胞裂解物中的表达情况。在PLN和MLN的裂解物中鉴定出了两种分子量分别为50 kD和90 kD的硫酸化糖蛋白,但在PP的裂解物中未鉴定出。在此我们表明,50-kD分子在体外器官培养中分泌,并且存在于正常动物的血液中。实际上,在体外试验中,正常血清可使淋巴细胞与HEV的结合抑制约50%。这种抑制活性可通过使血清通过L-选择素-IgG柱而去除,其分子量约为50 kD。我们推测了归巢受体配体分泌的可能原因。